Literature DB >> 10229546

Cyto-adherence studies of the adhesin P50 of Mycoplasma hominis.

Annette Kitzerow, Ulrich Hadding, Birgit Henrich.   

Abstract

Recombinant peptides of Mycoplasma hominis adhesin P50 were expressed in Escherichia coli to investigate which regions of the P50 molecule are responsible for cyto-adherence. The respective DNA fragments were obtained by PCR amplification of the p50 gene with the use of mutating oligonucleotides to change the TGA codons of mycoplasma to TGG codons, which are translated in E. coli as tryptophan. The resulting three clones (I, I+II and I+III) contained regions of P50 which closely represent the repeat regions A, A+B and A+C. After expression in E. coli, the polyhistidine-tagged recombinant peptides were purified by metal chelation chromatography. The three recombinant peptides were detected in Western blot analysis by a polyclonal antiserum directed against M. hominis FBG and two P50-specific monoclonal antibodies, BA10 and BG2. Each of the three recombinant peptides I, I+II and I+III was able to adhere to immobilised HeLa cells in an adhesion assay. The cyto-adhesion of the peptides could be inhibited by pre-incubation with the appropriate antibody. Therefore, it is suggested that adherence may be mediated by all regions of the P50 molecule. Attachment of the recombinant peptides to immobilised HeLa cells was inhibited by high mol. wt dextran sulphate (MW 500000), indicating that the respective P50 regions bind to sulphatides on the host cell membrane.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229546     DOI: 10.1099/00222615-48-5-485

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

1.  Molecular design of Mycoplasma hominis Vaa adhesin.

Authors:  T Boesen; N U Fedosova; M Kjeldgaard; S Birkelund; G Christiansen
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  OppA, the substrate-binding subunit of the oligopeptide permease, is the major Ecto-ATPase of Mycoplasma hominis.

Authors:  Miriam Hopfe; Birgit Henrich
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

3.  Identification and functional mapping of the Mycoplasma fermentans P29 adhesin.

Authors:  Spencer A Leigh; Kim S Wise
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

4.  Complexity of the Mycoplasma fermentans M64 genome and metabolic essentiality and diversity among mycoplasmas.

Authors:  Hung-Wei Shu; Tze-Tze Liu; Huang-I Chan; Yen-Ming Liu; Keh-Ming Wu; Hung-Yu Shu; Shih-Feng Tsai; Kwang-Jen Hsiao; Wensi S Hu; Wailap Victor Ng
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

Review 5.  Molecular mechanisms of pathogenicity of Mycoplasma mycoides subsp. mycoides SC.

Authors:  Paola Pilo; Joachim Frey; Edy M Vilei
Journal:  Vet J       Date:  2006-12-06       Impact factor: 2.688

6.  Validation of a novel Mho microarray for a comprehensive characterisation of the Mycoplasma hominis action in HeLa cell infection.

Authors:  Birgit Henrich; Freya Kretzmer; René Deenen; Karl Köhrer
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

7.  Genome-Wide Analysis of the First Sequenced Mycoplasma capricolum subsp. capripneumoniae Strain M1601.

Authors:  Shengli Chen; Huafang Hao; Ping Zhao; François Thiaucourt; Ying He; Pengcheng Gao; Han Guo; Wenheng Ji; Zhanhui Wang; Zhongxin Lu; Yuefeng Chu; Yongsheng Liu
Journal:  G3 (Bethesda)       Date:  2017-09-07       Impact factor: 3.154

Review 8.  Paradigms of Protist/Bacteria Symbioses Affecting Human Health: Acanthamoeba species and Trichomonas vaginalis.

Authors:  Fiona L Henriquez; Ronnie Mooney; Timothy Bandel; Elisa Giammarini; Mohammed Zeroual; Pier Luigi Fiori; Valentina Margarita; Paola Rappelli; Daniele Dessì
Journal:  Front Microbiol       Date:  2021-01-07       Impact factor: 5.640

9.  Host cell responses to persistent mycoplasmas--different stages in infection of HeLa cells with Mycoplasma hominis.

Authors:  Miriam Hopfe; René Deenen; Daniel Degrandi; Karl Köhrer; Birgit Henrich
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.